Annex V states that dividend income from subsidiaries, associates and joint ventures which are outside the scope of consolidation shall be reported within "Share of profit or (-) loss of investments in subsidiaries, joint ventures and associates". Based on this statement we need clarification regarding the line in which the investments in subsidiaries that are not included in the prudential scope of consolidated should be reported in the balance sheet. Annex V p1.12 states with regard to accounting portfolios that "these aggregations do not include investments in subsidiaries, joint ventures and associates [...]." Example: A subsidiary is not included in the prudential scope of consolidation and should therefore be included in the IAS category "Available for sale". Should the carrying amount of this investment be reported in line item F 01.01, r140, c010 or in line item F 01.01, r260, c010? If it needs to be included in line item F 01.01, r260, c010: How should those investments be measured according to IFRS at the reporting date (at cost vs. at fair value)?
Information required in order to properly classify and measure investments in subsidiaries that are not included in the prudential scope of consolidation.
The general provisions of Annex V (Part 1, section 4.1, paragraph 12) clearly state that the investments in subsidiaries, joint ventures and associates should not be included in any "accounting portfolio".
From this starting point, associates as well as subsidiaries and joint ventures which are not included in the prudential scope of consolidation should be included in {F 01.01, r260, c010}.
As stated in Article 18(5) of the Regulation (EU) No. 575/2013 (CRR), the competent authorities shall determine how these investments should be measured, being the equity method an option or a requirement and without it constituting the inclusion of the undertaking concerned in supervision on a consolidated basis.
If the equity method is followed for their measurement: